Immune Checkpoint Inhibitors in Head and Neck Cancer: Summary of Key Points for Practice

In slides from Clinical Care Options (CCO), experts provide perspectives on updates in biomarker testing and targeted therapy across GI cancers

John L. Marshall, MD
Program Director Christopher H. Lieu, MD Manish A. Shah, MD Released: January 19, 2023

Downloadable slideset from a live meeting series for endocrinologists featuring best practices for biomarker testing and the latest evidence on targeted therapies for advanced thyroid cancer, from Clinical Care Options (CCO)

Maria E Cabanillas, MD Lori J. Wirth, MD Released: January 4, 2023

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered lung and thyroid cancer

Saad A. Khan, MD Sandip P. Patel, MD Released: November 17, 2022

Downloadable resource on the role of RET and NTRK aberrations in lung and thyroid cancer, including guidance on testing and review of the clinical data on RET and NTRK inhibitor therapy for these diseases, from Clinical Care Options (CCO)